Zelenskyy furious as Trump announces deal to buy Russian diesel 10. October 2026 (01:39) President says deal essential to lower US fuel prices but move set to create fresh crisis with Ukraine and Nato alliesUS politics – live updatesDonald Trump was on a fresh collision course with the Ukrainian president, Volodymyr Zelenskyy, and European allies on Friday after a stunning agreement to buy Russian diesel, upending years of US and western pressure on the Kremlin to end its four-and-a-half year war against Ukraine.Zelenskyy reacted furiously to Trump’s announcement of the deal with President Vladimir Putin of Russia, calling it “absolutely terrible” and “not fair and not honest”. Continue reading...(The Guardian)
Headteachers threaten strike ballots after losing confidence in Ofsted 10. October 2026 (01:01) Unions tell government to fix ‘overbearing mess’ of inspection regime and its impact on staff wellbeing – or risk industrial actionTensions between England’s headteachers and Ofsted are developing into a crisis after school leadership unions said they had no confidence in the watchdog and would hold strike ballots unless “significant wellbeing issues” caused by Ofsted’s inspections regime were fixed.The Association of School and College Leaders (ASCL), which includes senior leaders in many secondary schools, described Ofsted’s inspection system as “an overbearing mess” and urged the government to pause inspections to stop teachers leaving the profession. Continue reading...(The Guardian)
Women with PMOS should get subsidised weight-loss drugs, Australian advocates say 10. October 2026 (01:00) With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-labelGet our breaking news email, free app or daily news podcastWomen living with a chronic hormonal condition should have access to taxpayer-funded weight-loss medications, advocates say.The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition. Continue reading...(The Guardian)
